Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Revenue

In the year 2025, Intravenous Infusions had annual revenue of 9.30M GHS, down -62.69%. Intravenous Infusions had revenue of 2.23M in the half year ending December 31, 2025, a decrease of -87.50%.

• Revenue: 9.30M
• Revenue Growth: -62.69%
• P/S Ratio: 1.47
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.30M	-15.64M	-62.69%
Dec 31, 2024	24.94M	-6.48M	-20.62%
Dec 31, 2023	31.42M	11.06M	54.34%
Dec 31, 2022	20.36M	-2.32M	-10.21%
Dec 31, 2021	22.67M	2.00M	9.69%